806 related articles for article (PubMed ID: 23183047)
1. PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells.
Finlay DK; Rosenzweig E; Sinclair LV; Feijoo-Carnero C; Hukelmann JL; Rolf J; Panteleyev AA; Okkenhaug K; Cantrell DA
J Exp Med; 2012 Dec; 209(13):2441-53. PubMed ID: 23183047
[TBL] [Abstract][Full Text] [Related]
2. mTORC1 regulates CD8+ T-cell glucose metabolism and function independently of PI3K and PKB.
Finlay DK
Biochem Soc Trans; 2013 Apr; 41(2):681-6. PubMed ID: 23514176
[TBL] [Abstract][Full Text] [Related]
3. Natural and inducible TH17 cells are regulated differently by Akt and mTOR pathways.
Kim JS; Sklarz T; Banks LB; Gohil M; Waickman AT; Skuli N; Krock BL; Luo CT; Hu W; Pollizzi KN; Li MO; Rathmell JC; Birnbaum MJ; Powell JD; Jordan MS; Koretzky GA
Nat Immunol; 2013 Jun; 14(6):611-8. PubMed ID: 23644504
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation.
Rao RR; Li Q; Gubbels Bupp MR; Shrikant PA
Immunity; 2012 Mar; 36(3):374-87. PubMed ID: 22425248
[TBL] [Abstract][Full Text] [Related]
5. Aberrant CD8+ T-cell responses and memory differentiation upon viral infection of an ataxia-telangiectasia mouse model driven by hyper-activated Akt and mTORC1 signaling.
D'Souza AD; Parish IA; McKay SE; Kaech SM; Shadel GS
Am J Pathol; 2011 Jun; 178(6):2740-51. PubMed ID: 21641396
[TBL] [Abstract][Full Text] [Related]
6. Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation.
Zhu Y; Pereira RO; O'Neill BT; Riehle C; Ilkun O; Wende AR; Rawlings TA; Zhang YC; Zhang Q; Klip A; Shiojima I; Walsh K; Abel ED
Mol Endocrinol; 2013 Jan; 27(1):172-84. PubMed ID: 23204326
[TBL] [Abstract][Full Text] [Related]
7. mTORC1 and mTORC2 selectively regulate CD8⁺ T cell differentiation.
Pollizzi KN; Patel CH; Sun IH; Oh MH; Waickman AT; Wen J; Delgoffe GM; Powell JD
J Clin Invest; 2015 May; 125(5):2090-108. PubMed ID: 25893604
[TBL] [Abstract][Full Text] [Related]
8. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
[TBL] [Abstract][Full Text] [Related]
9. Tsc1 promotes the differentiation of memory CD8+ T cells via orchestrating the transcriptional and metabolic programs.
Shrestha S; Yang K; Wei J; Karmaus PW; Neale G; Chi H
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14858-63. PubMed ID: 25271321
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism.
Macintyre AN; Finlay D; Preston G; Sinclair LV; Waugh CM; Tamas P; Feijoo C; Okkenhaug K; Cantrell DA
Immunity; 2011 Feb; 34(2):224-36. PubMed ID: 21295499
[TBL] [Abstract][Full Text] [Related]
11. Natural killer group 2D and CD28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD8+ T-cell differentiation.
McQueen B; Trace K; Whitman E; Bedsworth T; Barber A
Immunology; 2016 Mar; 147(3):305-20. PubMed ID: 26661515
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
Gong T; Cui L; Wang H; Wang H; Han N
J Transl Med; 2018 Jun; 16(1):164. PubMed ID: 29898734
[TBL] [Abstract][Full Text] [Related]
13. PDGF receptor-β uses Akt/mTORC1 signaling node to promote high glucose-induced renal proximal tubular cell collagen I (α2) expression.
Das F; Ghosh-Choudhury N; Venkatesan B; Kasinath BS; Ghosh Choudhury G
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F291-F307. PubMed ID: 28424212
[TBL] [Abstract][Full Text] [Related]
14. Foxp3 and Toll-like receptor signaling balance T
Gerriets VA; Kishton RJ; Johnson MO; Cohen S; Siska PJ; Nichols AG; Warmoes MO; de Cubas AA; MacIver NJ; Locasale JW; Turka LA; Wells AD; Rathmell JC
Nat Immunol; 2016 Dec; 17(12):1459-1466. PubMed ID: 27695003
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8(+) T cell differentiation.
Pollizzi KN; Sun IH; Patel CH; Lo YC; Oh MH; Waickman AT; Tam AJ; Blosser RL; Wen J; Delgoffe GM; Powell JD
Nat Immunol; 2016 Jun; 17(6):704-11. PubMed ID: 27064374
[TBL] [Abstract][Full Text] [Related]
16. The E-Id protein axis modulates the activities of the PI3K-AKT-mTORC1-Hif1a and c-myc/p19Arf pathways to suppress innate variant TFH cell development, thymocyte expansion, and lymphomagenesis.
Miyazaki M; Miyazaki K; Chen S; Chandra V; Wagatsuma K; Agata Y; Rodewald HR; Saito R; Chang AN; Varki N; Kawamoto H; Murre C
Genes Dev; 2015 Feb; 29(4):409-25. PubMed ID: 25691468
[TBL] [Abstract][Full Text] [Related]
17. The insulin-PI3K/TOR pathway induces a HIF-dependent transcriptional response in Drosophila by promoting nuclear localization of HIF-alpha/Sima.
Dekanty A; Lavista-Llanos S; Irisarri M; Oldham S; Wappner P
J Cell Sci; 2005 Dec; 118(Pt 23):5431-41. PubMed ID: 16278294
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
19. mTORC1 alters the expression of glycolytic genes by regulating KPNA2 abundances.
Chen X; Zhu Y; Wang Z; Zhu H; Pan Q; Su S; Dong Y; Li L; Zhang H; Wu L; Lou X; Liu S
J Proteomics; 2016 Mar; 136():13-24. PubMed ID: 26844761
[TBL] [Abstract][Full Text] [Related]
20. Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism.
Chen GQ; Tang CF; Shi XK; Lin CY; Fatima S; Pan XH; Yang DJ; Zhang G; Lu AP; Lin SH; Bian ZX
Oncotarget; 2015 Sep; 6(27):24148-62. PubMed ID: 26160839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
